A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...
James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda." ...
The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according ...
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
20hon MSN
OnePlus is hoping the OnePlus Watch 3 could get FDA approval for its new sleep apnea detection feature, bringing it one step ...
We still don’t know the full extent of layoffs at the FDA, though they are widespread. That could reduce oversight of the ...
On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight ...
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results